Location History:
- Bagsvaerd, DK (2008)
- Lyngby, DK (2014)
Company Filing History:
Years Active: 2008-2014
Title: **Anette Sams Nielsen: Innovator in Medicinal Chemistry**
Introduction
Anette Sams Nielsen is a prominent inventor based in Lyngby, Denmark. With a robust portfolio of inventions, she has made significant contributions to the field of medicinal chemistry, particularly through her work in developing innovative peptide compounds.
Latest Patents
Anette Sams Nielsen holds two patents that reflect her pioneering research in the area of therapeutic peptides. Her latest patents include:
1. **Derivatives of CGRP** - This invention focuses on acylated CGRP compounds that possess a linker, which grants them prolonged action, making them valuable as medicaments.
2. **GLP-2 Compounds, Formulations, and Uses Thereof** - This patent pertains to novel human glucagon-like peptide-2 (GLP-2) peptides and derivatives. These compounds exhibit a protracted profile of action and include polynucleotide constructs encoding such peptides, along with vectors and host cells that express them. The patent also covers pharmaceutical compositions, uses, and methods of treatment.
Career Highlights
Anette is currently employed at Novo Nordisk A/S, a leading global healthcare company. Her role there highlights her expertise and dedication to advancing medical treatments through innovative research.
Collaborations
Throughout her career, Anette has collaborated with notable colleagues in her field, including Lars Thim and Susanne Bang. These partnerships have allowed her to further her research endeavors and contribute to significant advancements in medicinal chemistry.
Conclusion
Anette Sams Nielsen stands out as an influential inventor with a focus on peptide-based therapies. Her work at Novo Nordisk A/S and her innovative patents underline her commitment to improving healthcare through targeted medicinal solutions. As she continues her research, her contributions will undoubtedly leave a lasting impact on the field.